glp 1 prescription canada 3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits Health Canada warns about fake

Respiratory effects of treatment with a glucagon-like peptide-1 receptor agonist in patients suffering from obesity and chronic obstructive pulmonary disease

Clinical studies have demonstrated that GLP-1 receptor agonists, including Ozempic , can support meaningful and sustained weight loss over extended periods

A: Yes, according to FDA prescribing information, all GLP-1 medications available through Ro are administered as subcutaneous (under-skin) injections: Frequency : Once weekly (same day each week) Injection sites : Abdomen, thigh, or upper arm (rotate sites) Needle size : Very small (similar to insulin needles) Administration time : Less than 1 minute Most members report that injection anxiety diminishes significantly after first few doses

How does this interact with CGM and AID systems

Emotional support helps alleviate anxiety and encourages the patient to actively participate in their diabetes management

What happens if you are allergic to a GLP-1 Receptor Agonist